A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection

Status:
Not yet recruiting

Trial end date:
2024-03-07

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy of the study intervention based on hepatitis B surface antigen (HBsAg) levels.

Phase 1

Janssen Research & Development, LLC

Tenofovir